Literature DB >> 3501006

Rectosigmoidoscopic findings during isolated rectal bleeding in the neonate.

C Dupont1, J Badoual, B Le Luyer, C Le Bourgeois, J P Barbet, M Voyer.   

Abstract

This study describes a group of 34 infants under 1 1/2 months of age presenting with isolated rectal bleeding not related to hemorrhagic disease of the newborn or to campylobacter infection and with spontaneously favorable evolution. Systematic rectosigmoidoscopy showed the presence of mucosal alterations in the form of either longitudinally stretched ecchymoses lying on a normal mucosa or diffuse ecchymotic patches dispersed on a congestive and friable mucosa, rarely associated to visible micro-ulcerations. Biopsies showed mucosal hemorrhage, capillary vessel congestion, and epithelial erosions, as well as various grades of inflammation. Clinical data indicate that this hemorrhagic colitis is a heterogeneous group where dietary protein intolerance may account for some cases.

Entities:  

Mesh:

Year:  1987        PMID: 3501006     DOI: 10.1097/00005176-198703000-00017

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  4 in total

Review 1.  Chronic inflammatory bowel disease.

Authors:  I W Booth
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Proctocolitis in breast fed infants: a contribution to differential diagnosis of haematochezia in early childhood.

Authors:  W Pumberger; G Pomberger; W Geissler
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

3.  Characteristics of neonates with isolated rectal bleeding.

Authors:  A Maayan-Metzger; N Ghanem; R Mazkereth; J Kuint
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

4.  Advanced criteria for clinicopathological diagnosis of food protein-induced proctocolitis.

Authors:  Jin-Bok Hwang; Moon Ho Park; Yu Na Kang; Sang Pyo Kim; Seong-Il Suh; Sin Kam
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.